Utang jangka cendhak marang modal Procaps Group S.A. (PROC)

Procaps Group S.A. - logo grafis emiten PROC

The price chart for Procaps Group S.A. (PROC) reflects a trend where the indicator currently stands at 0.00. The business relies on exclusive capsule patents and influential connections in Latin America under strict FDA oversight. Procaps Group S.A. (PROC) attracts the region's leading technologists by offering them accelerated career growth. Production capacities are fully utilized, while equipment for monitoring product geometry is being actively upgraded.

Rasio tanggungan utang jangka cendhak marang modal Procaps Group SA (PROC): kanggo periode 04.07.2022 - 16.02.2025
Produk merek Procaps Group

To find fundamental support in Procaps Group S.A. (PROC), it is essential to evaluate the balance between expansion and stability, where the short-term debt-to-equity ratio measures the proportion of liabilities maturing within one year relative to equity, reflecting the global capsule manufacturer's reliance on current borrowing, which, given the brand's strong B2B reputation, allows for the management of interest rate risks during business scaling.

Pesaing Procaps Group S.A.

Haleon Group (HLN) - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal Kenvue Health (KVUE)|Utang jangka cendhak marang modal VRNA (Verona Pharma plc)|jyongbio.com - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Ligand (LGND)|AMRX: Rasio tanggungan utang jangka cendhak marang modal|PRGO (Perrigo Company) - Utang jangka cendhak marang ekuitas|Alvotech Biopharmaceuticals (ALVO) - Rasio utang jangka cendhak marang ekuitas|LQDA (Liquidia Corporation) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal glpg.com (GLPG)|ANI Pharmaceuticals, Inc. (ANIP) - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal MNKD (MannKind Corp)|AMPH: Utang jangka cendhak marang ekuitas|PCRX - Kewajiban jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas ARS Pharmaceuticals SPRY|TBPH - Rasio silihan jangka cendhak marang modal|Utang jangka cendhak marang modal Aquestive Therapeutics, Inc. AQST|scPharmaceuticals (SCPH) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal TECX (Tectonic Therapeutic Inc.)|Kewajiban jangka cendhak marang modal TNXP|China SXT Pharmaceuticals (SXTC) - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal EPRX (eupraxiapharma.com)|BioHarvest Sciences Inc. (BHST) - Utang jangka cendhak marang ekuitas|Invizyne Technologies - Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Oramed Pharma (ORMP)|ENTX: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas HYFT|abvcpharma.com (ABVC) - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal CPIX|Rasio utang jangka cendhak marang ekuitas Quantum BioPharma Ltd.|Utang jangka cendhak marang modal FGEN|Utang jangka cendhak marang modal TELO (Telomir Pharmaceuticals Corp)|Rani Therapeutics Holdings, Inc. (RANI) - Utang jangka cendhak marang ekuitas|Synergy CHC Corp. - Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas RLYB (Rallybio Corp.)|Lexaria Bioscience (LEXX) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Pulmatrix Corp PULM|Pheton Holdings (PTHL) - Rasio tanggungan utang jangka cendhak marang modal|Aptorum Group Ltd - Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas LYRA|Impact BioMedical (IBO) - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal TNFA (tnfpharma.com)|YCBD: Utang jangka cendhak marang ekuitas|PRFX - Kewajiban jangka cendhak marang modal|Auris Medical - Rasio utang jangka cendhak marang ekuitas|LIPO: Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas OptiNose (OPTN)|Kewajiban jangka cendhak marang ekuitas Pieris Pharmaceuticals Inc|PTPI - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal QLI|SLRN (Acelyrin, Inc.) - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal tffpharma.com TFFP